Clinical Trials Logo

Clinical Trial Summary

This is a single center, retrospective, observational cohort study to assess the safety and efficacy of drug coated balloon (DCB) angioplasty in all forms of coronary artery disease. The Investigators intend to report outcomes of all patients who received DCB angioplasty at their center during the above mentioned period for up to 10 years.


Clinical Trial Description

The Investigators expect to assess outcomes of all patients who received Drug Coated Balloon Angioplasty treatment, which is a novel therapy as opposed to standard Drug Eluting Stent insertion, for all types of coronary artery disease from 01/01/2009 till 31/12/2015 in their center. The Investigators believe the number exceeds 1000 patients. The Investigators plan to collect demographic and procedural data from their existing data base. They will request up to date follow-up events from NICOR (National Institute for Cardiovascular Outcomes Research, UK) in 2017(data ending December 2016), by which time all patientswould have had minimum of 12 months follow up. The Investigators plan to incorporate these findings to their data set and report the comprehensive outcomes. Primary end point will be major adverse cardiac outcomes (MACE) defined as a composite of death, myocardial infarction and target vessel revascularisation. Secondary end points will be acute vessel closure and target lesion revascularisation. The Investigators also have a long term plan of requesting follow-up events from NICOR for up to 10 years, so they can report on long term outcomes of drug coated balloon treatment. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03603210
Study type Observational
Source Norfolk and Norwich University Hospitals NHS Foundation Trust
Contact
Status Active, not recruiting
Phase
Start date September 11, 2017
Completion date January 31, 2027

See also
  Status Clinical Trial Phase
Completed NCT04097912 - Study to Gather Information to What Extent Patients Follow the Treatment Regimen of Low-dose Aspirin for Primary and Secondary Prevention of Diseases of the Heart and Blood Vessels
Completed NCT01941355 - Trial of Rehabilitation in Phase 1 After Coronary Artery Bypass Grafting N/A
Completed NCT00151658 - Sirolimus Eluting Stents in Complex Coronary Lesions (SCANDSTENT) N/A
Recruiting NCT04193475 - Machine Learning in Quantitative Stress Echocardiography
Completed NCT02290262 - SheppHeartCABG - Phase One Rehabilitation After Coronary Artery Bypass Grafting N/A
Active, not recruiting NCT03736018 - Randomised Controlled Trial to Assess Whether Computed Tomography Cardiac Angiography Can Improve Invasive Coronary Angiography in Bypass Surgery Patients N/A
Completed NCT02849067 - Hemodynamic Responses of Stable Ischemic Heart Disease Patients to a Comedy Session N/A
Recruiting NCT05045118 - The Impact of Structured Patient Education Material (SPEM) in Improving Clinical and Behavioural Outcomes in Home-based Cardiac Rehabilitation Program Participants: A Pilot Study N/A
Completed NCT04901767 - Coronary Artery Endothelial Dysfunction With Drug Coated Balloons
Enrolling by invitation NCT03674255 - Echocardiography: Value and Accuracy at REst and STress
Active, not recruiting NCT03171311 - The OCTOBER Trial - European Trial on Optical Coherence Tomography Optimized Bifurcation Event Reduction (OCTOBER) N/A
Recruiting NCT04768283 - Cardiac Rehabilitation and Additional Physical Training in Elderly Patients After Acute Coronary Syndrome N/A
Completed NCT02315001 - Liraglutide to Improve corONary Haemodynamics During Exercise streSS Phase 2
Completed NCT01796353 - Effects of a Comprehensive Sexual Rehabilitation Programme in Heart Patients N/A
Recruiting NCT04061525 - Motion and IntraCoronary Ecg Ischemia Development Study (MICE)
Recruiting NCT04674449 - iCorMicA - Stratified Medicine in Angina N/A
Active, not recruiting NCT02623140 - BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX Phase 4
Completed NCT03646097 - Impact of Real-time Angiographic Co-registered OCT on PCI Results - the OPTICO-integration II Study N/A
Completed NCT02053818 - Remifentanil/Sufentanil for CABG+/-AVR Evaluated by Recovery, Cognitive Function, Haemodynamics and Biochemical Markers. Phase 4
Recruiting NCT04014140 - iFR Guided Coronary Artery Bypass Grafting Surgery